Entity Common Stock, Shares Outstanding of ARTELO BIOSCIENCES, INC. from 10 Apr 2015 to 10 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ARTELO BIOSCIENCES, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 10 Apr 2015 to 10 Nov 2025.
  • ARTELO BIOSCIENCES, INC. Entity Common Stock, Shares Outstanding for the quarter ending 10 Nov 2025 was 2,018,746, a 37% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

ARTELO BIOSCIENCES, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,018,746 -1,208,954 -37% 10 Nov 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 1,321,552 -1,906,148 -59% 12 Aug 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 3,281,032 +53,332 +1.7% 27 Feb 2025 10-K 03 Mar 2025 2024 FY
Q3 2024 3,227,700 +38,741 +1.2% 11 Nov 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 3,227,700 +342,012 +12% 12 Aug 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 3,227,700 +372,012 +13% 22 Mar 2024 10-K 25 Mar 2024 2023 FY
Q3 2023 3,188,959 +333,271 +12% 10 Nov 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 2,885,688 -39,708,293 -93% 10 Aug 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 2,855,688 -39,445,325 -93% 27 Mar 2023 10-K 31 Mar 2023 2022 FY
Q3 2022 2,855,688 -39,445,325 -93% 07 Nov 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 42,593,981 +18,099,999 +74% 08 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 42,301,013 +19,167,901 +83% 18 Mar 2022 10-KT 21 Mar 2022 2022 Q1
Q4 2021 42,301,013 +26,589,426 +169% 10 Jan 2022 10-Q 12 Jan 2022 2022 Q1
Q3 2021 42,301,013 +27,189,426 +180% 05 Nov 2021 10-K 29 Nov 2021 2021 FY
Q2 2021 24,493,982 +19,997,616 +445% 08 Jul 2021 10-Q 12 Jul 2021 2021 Q3
Q1 2021 23,133,112 +19,705,713 +575% 12 Apr 2021 10-Q 13 Apr 2021 2021 Q2
Q4 2020 15,711,587 +12,284,188 +358% 13 Jan 2021 10-Q 14 Jan 2021 2021 Q1
Q3 2020 15,111,587 30 Oct 2020 10-K 04 Nov 2020 2020 FY
Q2 2020 4,496,366 +1,094,379 +32% 10 Jul 2020 10-Q 13 Jul 2020 2020 Q3
Q1 2020 3,427,399 -12,452,090 -78% 10 Apr 2020 10-Q 13 Apr 2020 2020 Q2
Q4 2019 3,427,399 -11,855,288 -78% 14 Jan 2020 10-Q 14 Jan 2020 2020 Q1
Q2 2019 3,401,987 -9,379,208 -73% 12 Jul 2019 10-Q 15 Jul 2019 2019 Q3
Q1 2019 15,879,489 +3,098,294 +24% 12 Apr 2019 10-Q 15 Apr 2019 2019 Q2
Q4 2018 15,282,687 +3,810,385 +33% 14 Jan 2019 10-Q 14 Jan 2019 2019 Q1
Q2 2018 12,781,195 +2,981,195 +30% 09 Jul 2018 10-Q 13 Jul 2018 2018 Q3
Q1 2018 12,781,195 +2,981,195 +30% 12 Apr 2018 10-Q/A 14 May 2018 2018 Q2
Q4 2017 11,472,302 +3,832,302 +50% 16 Jan 2018 10-Q/A 21 Mar 2018 2018 Q1
Q2 2017 9,800,000 +2,160,000 +28% 07 Jul 2017 10-Q 21 Jul 2017 2017 Q3
Q1 2017 9,800,000 +2,160,000 +28% 14 Apr 2017 10-Q 14 Apr 2017 2017 Q2
Q4 2016 7,640,000 0 0% 06 Jan 2017 10-Q 10 Jan 2017 2017 Q1
Q2 2016 7,640,000 +790,000 +12% 30 Jun 2016 10-Q 05 Jul 2016 2016 Q3
Q1 2016 7,640,000 +1,640,000 +27% 31 Mar 2016 10-Q 01 Apr 2016 2016 Q2
Q4 2015 7,640,000 14 Jan 2016 10-Q 14 Jan 2016 2016 Q1
Q2 2015 6,850,000 15 Jul 2015 10-Q 15 Jul 2015 2015 Q3
Q1 2015 6,000,000 10 Apr 2015 10-Q 14 Apr 2015 2015 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.